Private equity firm Goldstone has lost its bid to lodge an appeal before damages are determined, after a judge found it invalidly terminated its managing director’s employment for standing in the way of a deal with her business partner’s son.
Private equity firm Goldstone has cited an “irretrievable breakdown” in the relationship between shareholders in seeking to appeal a ruling that found it liable for oppression.
A private equity fund is challenging a ruling that it acted in an “oppressive” and “unfairly prejudicial” way towards its managing director, who a judge found was invalidly sacked for standing in the way of a deal with her business partner’s son.
A group of Australia’s leading beef and dairy companies has failed to strike-out a suit alleging their genetic testing system for cattle infringes the patent of a US genomics company, with a judge rejecting objections to the phrase ‘further or in the alternative’.
An appeals court has found that a claim by indie duo Angus & Julia Stone alleging their former talent management company owes $2.8 million in overcharges should proceed in a UK court.
US animal drug manufacturer Zoetis has lost its challenge a ruling that chucked out three of its patents for a single-dose vaccine to protect pigs from enzootic pneumonia.
UK talent management company TaP Management has filed an appeal after a judge dismissed its bid to permanently stay a case by Australian musical duo Angus & Julia Stone, who allege their former manager overcharged them by $2.8 million.
US animal drug manufacturer Zoetis has been granted leave to appeal a ruling that invalidated three of its patents covering pig vaccines.
German drug maker Boehringer has prevailed in its Federal Court fight against US rival Zoetis over the validity of three patents covering pig vaccines.
A judge has upheld findings from IP Australia that South Korean biotech ToolGen’s genome editing technology CRISPR is not patentable, but given the company one more chance to seek to amend its application.